Robeco Institutional Asset Management B.V. Raises Stock Holdings in Danaher Corporation $DHR

08 Jan 2026, 06:08 by Scott Moore · The Cerbat Gem

Robeco Institutional Asset Management B.V. raised its stake in Danaher Corporation (NYSE:DHR – Free Report) by 19.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 210,609 shares of the conglomerate’s stock after acquiring an additional 34,885 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Danaher were worth $41,755,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also added to or reduced their stakes in DHR. White Pine Capital LLC boosted its holdings in shares of Danaher by 1.4% during the second quarter. White Pine Capital LLC now owns 3,494 shares of the conglomerate’s stock worth $690,000 after purchasing an additional 49 shares during the period. Boyd Watterson Asset Management LLC OH raised its holdings in shares of Danaher by 2.1% during the second quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate’s stock valued at $499,000 after acquiring an additional 51 shares in the last quarter. Worth Financial Advisory Group LLC lifted its stake in Danaher by 4.6% in the second quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate’s stock worth $236,000 after acquiring an additional 53 shares during the period. Howard Capital Management Group LLC increased its position in Danaher by 4.8% during the 3rd quarter. Howard Capital Management Group LLC now owns 1,159 shares of the conglomerate’s stock valued at $230,000 after purchasing an additional 53 shares during the period. Finally, Bruce G. Allen Investments LLC raised its holdings in Danaher by 13.1% in the 2nd quarter. Bruce G. Allen Investments LLC now owns 467 shares of the conglomerate’s stock worth $92,000 after purchasing an additional 54 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of Danaher stock opened at $235.60 on Thursday. The stock has a market cap of $166.41 billion, a P/E ratio of 48.58, a P/E/G ratio of 4.21 and a beta of 0.89. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. The stock’s fifty day moving average is $224.91 and its 200 day moving average is $210.05. Danaher Corporation has a one year low of $171.00 and a one year high of $258.23.

Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same quarter in the prior year, the business posted $1.71 earnings per share. The business’s quarterly revenue was up 4.4% on a year-over-year basis. Sell-side analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be issued a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, December 26th. This represents a $1.28 annualized dividend and a yield of 0.5%. Danaher’s payout ratio is currently 26.39%.

Insiders Place Their Bets

In other Danaher news, Director Teri List sold 3,298 shares of the firm’s stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the sale, the director directly owned 20,762 shares of the company’s stock, valued at $4,702,593. This trade represents a 13.71% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Brian W. Ellis sold 21,776 shares of the company’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the completion of the transaction, the senior vice president directly owned 14,553 shares of the company’s stock, valued at approximately $3,190,454.19. This trade represents a 59.94% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 30,248 shares of company stock worth $6,609,663 over the last three months. 11.10% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. HSBC upped their price target on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research note on Monday, December 1st. Morgan Stanley started coverage on shares of Danaher in a research note on Monday, December 1st. They set an “overweight” rating and a $270.00 price objective for the company. Rothschild & Co Redburn reiterated a “neutral” rating and issued a $220.00 target price (down previously from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Jefferies Financial Group raised their price target on shares of Danaher from $245.00 to $255.00 and gave the company a “buy” rating in a research report on Wednesday, December 17th. Finally, Cowen restated a “buy” rating on shares of Danaher in a report on Wednesday. Twenty-one equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $249.92.

Check Out Our Latest Stock Report on Danaher

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.